We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
+$1.68B
Cap. Flow
+$21M
Cap. Flow %
0.07%
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$39M
2
HPE icon
Hewlett Packard
HPE
+$35.3M
3
SYF icon
Synchrony
SYF
+$29.5M
4
CMCSA icon
Comcast
CMCSA
+$25.4M
5
ILMN icon
Illumina
ILMN
+$13.5M

Sector Composition

Rank Sector Weight
1 Financials 15.31%
2 Healthcare 14.62%
3 Technology 14.1%
4 Industrials 10.66%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMAT icon
2751
LeMaitre Vascular
LMAT
$1.85B
$216K ﹤0.01%
+12,508
New +$181K
HSKA
2752
DELISTED
Heska Corp
HSKA
$216K ﹤0.01%
+5,584
New +$185K
CORR
2753
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$215K ﹤0.01%
14,520
+572
+4% +$12.7K
CTIC
2754
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$215K ﹤0.01%
17,483
+2,894
+20% +$38.6K
CWCO icon
2755
Consolidated Water Co
CWCO
$474M
$214K ﹤0.01%
17,452
+2,335
+15% +$27.2K
FMX icon
2756
Fomento Económico Mexicano
FMX
$43B
$214K ﹤0.01%
+2,319
New +$223K
SGA icon
2757
Saga Communications
SGA
$58.9M
$214K ﹤0.01%
+5,559
New +$229K
NM
2758
DELISTED
Navios Maritime Holdings Inc.
NM
$214K ﹤0.01%
12,244
+1,393
+13% +$26.6K
TNAV
2759
DELISTED
Telenav Inc.
TNAV
$214K ﹤0.01%
37,599
+1,390
+4% +$9.58K
ECYT
2760
DELISTED
Endocyte, Inc. Common Stock
ECYT
$214K ﹤0.01%
53,465
+4,215
+9% +$19.4K
RENX
2761
DELISTED
RELX N.V.
RENX
$214K ﹤0.01%
12,686
-571
-4% -$9.67K
ITUB icon
2762
Itaú Unibanco
ITUB
$92.6B
$213K ﹤0.01%
74,363
+2,495
+3% +$7.92K
USLM icon
2763
United States Lime & Minerals
USLM
$3.37B
$213K ﹤0.01%
+19,370
New +$198K
SPNE
2764
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$213K ﹤0.01%
12,375
+800
+7% +$12.6K
NAVB
2765
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$213K ﹤0.01%
8,024
+626
+8% +$21.7K
AVHI
2766
DELISTED
A V Homes, Inc.
AVHI
$213K ﹤0.01%
16,619
+250
+2% +$3.32K
KYO
2767
DELISTED
Kyocera Adr
KYO
$212K ﹤0.01%
+4,587
New +$217K
NTLS
2768
DELISTED
NTELOS HLDGS CORP COM
NTLS
$212K ﹤0.01%
23,197
-475
-2% -$4.34K
ATEN icon
2769
A10 Networks
ATEN
$2.2B
$211K ﹤0.01%
32,212
+2,615
+9% +$18.1K
CRD.B icon
2770
Crawford & Co Class B
CRD.B
$570M
$211K ﹤0.01%
39,729
+1,800
+5% +$10.4K
TIPT icon
2771
Tiptree Inc
TIPT
$661M
$210K ﹤0.01%
34,222
+4,830
+16% +$32.5K
OXFD
2772
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$210K ﹤0.01%
18,220
+1,860
+11% +$23K
SQNM
2773
DELISTED
SEQUENOM INC NEW
SQNM
$210K ﹤0.01%
127,991
+10,380
+9% +$17.8K
IMDZ
2774
DELISTED
Immune Design Corp.
IMDZ
$209K ﹤0.01%
+10,416
New +$179K
IMUX icon
2775
Immunic
IMUX
$192M
$208K ﹤0.01%
45
+9
+25% +$29.4K

Similar funds

RhumbLine Advisers's Q4 2015 Portfolio in Review

As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

  • RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
  • RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
  • RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
  • RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
  • RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
  • RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.

Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.